HOME >> MEDICINE >> NEWS
New digital tool unveiled to help business avoid SARS risks

PITTSBURGH Carnegie Mellon researcher Asim Smailagic and Dan Siewiorek with their students from Rapid Prototyping of Computer Systems class, will demonstrate a new wireless meeting space designed to save time and money for businesses April 30 at 1:30 p.m. in room 2202 of Hamburg Hall.

Dubbed project BARN, the interactive physical and digital workspace supports collaborative project teams by providing the digital equivalent of dedicated project rooms. These new smart rooms can store important computer files, recognize meeting participants and provide unlimited security for sensitive research data.

At the flip of the switch, businesses can now turn any room into an information crossroads where a variety of digital tools and novel interactive devices can support seamless group collaborations from anywhere in the world, including Hong Kong where business trade is off substantially because of the deadly virus severe acute respiratory syndrome (SARS).

And because public health officials think SARS is spread by close contact between people, executives are seeking new ways to conduct business, including increased use of the phone and tele-conferencing, Carnegie Mellon researchers said.

Our powerful BARN tools permit users to organize, retrieve, store and share information from multiple modes of collaboration, said Smailagic, a principal research scientist with Carnegie Mellons Institute for Complex Engineered Systems.

Some of the digital tools include specially-designed computer boards, remote interactive devices and special 3-D audio systems for improved presentation of meeting information and knowledge transfer.

This project supports the nomadic character of todays business environment where mobile extension supports remote collaboration, said Smailagic, who won a prestigious Carnegie Science Center Award this month for innovative work in infor
'"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
21-Apr-2003


Page: 1 2

Related medicine news :

1. New computer technique differentiates malignant and benign calcifications on digital mammograms
2. New digital technique improves mammography results
3. Navy medics going digital
4. Harvard Medical School new digital library to feature MD Consult full text medical resources
5. Learning with a digital brain
6. A milestone in colorectal cancer unveiled Avastin(TM) confers unprecedented survival advantage
7. Media Advisory-- Results of California autism epidemiology study to be unveiled
8. CONVINCE trial results unveiled at annual hypertension meeting
9. New studies on Alzheimers, depression unveiled at geriatric psychiatry conference
10. Genetically targeted therapies create opportunities to do business in new ways
11. NJIT business incubator helps start-up companies move out of the lab and into the marketplace

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New digital tool unveiled help business avoid SARS risks

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: